Look at recent research identifying a shared surface protein enabling immune therapies to target solid tumors and their protective microenvironment.
Key Takeaways
- Two independent teams identified GPNMB as a shared cell surface target
- GPNMB-targeted engineered T cells cleared tumors in mice and in organoids
- Single patient infusion stabilized metastatic soft‑tissue cancer for three months without severe toxicity